Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S0RX
|
|||
| Former ID |
DIB005275
|
|||
| Drug Name |
ATGC-OP0359
|
|||
| Synonyms |
Immunotherapeutic (prostate cancer), Avanti Therapeutics; Herpes simplex thymidine kinase (AV-tk)-encoding adenoviralvector (intra-tumoral) + antiherpetic prodrug (oral) (prostate cancer), Avanti
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Investigative | [1] | |
| Company |
Avanti Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.